Company / Free Cash Flow
Bionano Genomics, Inc. Free Cash Flow History
FY2018-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$38.3M
FY2020
5-year range
-
FY2018-FY2020
Trend
-29.5%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -$20M to -$38M over the past 2 years.
Based on SEC 10-K filings.
-$38M in FY2020.
Declined from -$20M to -$38M over the past 2 years.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2020, free cash flow decreased 29.5% year-over-year.
Company context
Key Data Points
- Altman Z-Score -8.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | -$38.3M | -29.5% |
| FY2019 | -$29.6M | -45.9% |
| FY2018 | -$20.3M | - |
As of FY2020 · SEC Form 10-K · Last checked Jun 22, 2026